RAREULTRAGENYX PHARMACEUTICAL IN
CUSIP 90400D108 · common stock
1 tracked investor held ULTRAGENYX PHARMACEUTICAL IN (RARE) at the end of Q3 2026, worth $4.5M. The largest holder was Adar1 Capital Management, with 0.2% of its portfolio. Adar1 Capital Management opened a new position this quarter.
Holders · Q3 2026
1
New holders
1
Value held
$4.5M
Quarter-end price (est.)
$15.03
Investors holding RARE · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.19% | 300,000 | $4.5M | NEW |
Options
| Investor | Type | Underlying shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management | Call | 20,000 | $300.6K | HOLD |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Sands Capital Management | 0.39% | 3,158,368 | $105.5M | EXIT |